ArticleBritish journal of pharmacology2005

Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.

Louise E Kennard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.